{
    "summary": "This bill, the John W. Walsh Alpha-1 Home Infusion Act of 2025, amends title XVIII of the Social Security Act to provide Medicare coverage for Alpha-1 Antitrypsin Deficiency Disorder treatment. It defines terms related to the treatment, including augmentation therapy and qualified home infusion therapy suppliers. The bill specifies payment mechanisms for intravenous administration kits and nursing services, implementing a payment system for home infusion services related to the treatment.  Conforming amendments are made, and the changes are slated to take effect January 1, 2027.",
    "tags": [
        "Healthcare",
        "Social security",
        "Healthcare access",
        "Elderly care"
    ],
    "category": "Healthcare & Public Health"
}